Fuad Mirzayev

World Health Organization - Pakistan — Pakistan

Medicine · Health Sciences

19h-index2.9kcitations45works57.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(36), Pneumocystis jirovecii pneumonia detection and treatment(13), Pneumonia and Respiratory Infections(11), Health Systems, Economic Evaluations, Quality of Life(6), Mycobacterium research and diagnosis(4)

Publications45 total

Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice
Clinical Microbiology Reviews·2025Open Access
GRADE Guidance: Using Thresholds for Judgments on Health Benefits and Harms in Decision Making (GRADE Guidance 42)
Annals of Internal Medicine·2025· 5 cited
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
The Lancet Infectious Diseases·2025· 297 citedOpen Access
Target regimen profiles for tuberculosis treatment
Bulletin of the World Health Organization·2024· 22 citedOpen Access
Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis
The Lancet Global Health·2024· 11 citedOpen Access
A publicly accessible global data repository – the WHO TB-IPD platform
IJTLD OPEN·2024· 1 citedOpen Access
Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort Study
Clinical Infectious Diseases·2024· 11 citedOpen Access
Multidrug-resistant tuberculosis
Nature Reviews Disease Primers·2024· 167 citedOpen Access
PUBLIC-PRIVATE PARTNERSHIP AND ITS ROLE IN SOLVING SOCIO-ECONOMIC PROBLEMS: ANALYSIS OF GLOBAL EXPERIENCE
AUDIT·2024Open Access
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis
Clinical Infectious Diseases·2023· 28 citedOpen Access
Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis
Nature Communications·2023· 35 citedOpen Access
Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease: systematic review and meta-analysis
EClinicalMedicine·2023· 39 citedOpen Access
Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis
Clinical Infectious Diseases·2023· 3 citedOpen Access
Co-administration of treatment for drug-resistant TB and hepatitis C
The International Journal of Tuberculosis and Lung Disease·2023· 5 citedOpen Access
Global Burden of Disease Due to Rifampicin-Resistant Tuberculosis in 2020: A Mathematical Modelling Analysis
SSRN Electronic Journal·2023Open Access
Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis
PLOS Global Public Health·2022· 8 citedOpen Access
Bridging the gap: key evidence needed to strengthen global policies to end TB
The International Journal of Tuberculosis and Lung Disease·2022· 1 cited
Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally
European Respiratory Journal·2022· 10 citedOpen Access
Practices of therapeutic drug monitoring in tuberculosis: an international survey
European Respiratory Journal·2022· 23 citedOpen Access
New treatment outcome definitions for drug-susceptible and drug-resistant tuberculosis: update from World Health Organization
2021
page 1 of 3Next →

Frequent Co-authors

Matteo Zignol(17), Linh Nguyen(12), Samuel G. Schumacher(12), Dennis Falzon(11), Medea Gegia(10), Tereza Kasaeva(7), Kerri Viney(6), Ernesto Jaramillo(6), Holger J. Schünemann(5), Giovanni Battista Migliori(5), Carole D. Mitnick(4), Karin Weyer(4), Nazir Ismail(4), Kristina Wallengren(4), Fabio Scano(4), Paul Nunn(4), Bruce Margot(4), Brian Williams(4), Alexander S. Pym(4), Lindiwe Mvusi(4)